Literature DB >> 8592334

Gonadal mosaicism for incontinentia pigmenti in a healthy male.

T T Kirchman1, M L Levy, R A Lewis, M H Kanzler, D L Nelson, A E Scheuerle.   

Abstract

Incontinentia pigmenti (IP) is a genodermatosis that segregates as an X linked dominant trait with male lethality. The disease has been linked to Xq28 in a number of studies. A few affected males have been documented, most of whom have a 47,XXY karyotype. We report a family with two paternally related half sisters, each affected with IP. The father is healthy, clinically normal, and has a 46,XY normal male karyotype. Linkage analysis of 12 polymorphic markers (two X linked and 10 autosomal) confirms paternity. X inactivation studies with the human androgen receptor (HUMARA) indicate that the paternal X chromosome is inactivated preferentially in each girl, implying that this chromosome carries the IP mutation, and that the father is a gonadal mosaic for the IP mutation.

Entities:  

Mesh:

Year:  1995        PMID: 8592334      PMCID: PMC1051742          DOI: 10.1136/jmg.32.11.887

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  Half chromatid mutations: transmission in humans?

Authors:  S M Gartler; U Francke
Journal:  Am J Hum Genet       Date:  1975-03       Impact factor: 11.025

2.  Letter: Half chromatid mutations may explain incontinentia pigmenti in males.

Authors:  W Lenz
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

3.  Rapid PCR analysis of the St14 (DXS52) VNTR.

Authors:  B Richards; R Heilig; I Oberlé; L Storjohann; G T Horn
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

4.  Selection against lethal alleles in females heterozygous for incontinentia pigmenti.

Authors:  B R Migeon; J Axelman; S Jan de Beur; D Valle; G A Mitchell; K N Rosenbaum
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

5.  The gene for incontinentia pigmenti is assigned to Xq28.

Authors:  A Sefiani; L Abel; S Heuertz; D Sinnett; L Lavergne; D Labuda; M C Hors-Cayla
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

6.  Incontinentia pigmenti: XXY male with a family history.

Authors:  J García-Dorado; P de Unamuno; E Fernández-López; J Salazar Veloz; M Armijo
Journal:  Clin Genet       Date:  1990-08       Impact factor: 4.438

7.  Incontinentia pigmenti. A world statistical analysis.

Authors:  R G Carney
Journal:  Arch Dermatol       Date:  1976-04

8.  Incontinentia pigmenti in a boy with Klinefelter's syndrome.

Authors:  A D Ormerod; M I White; E McKay; A W Johnston
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

9.  Incontinentia pigmenti in a father and his daughter.

Authors:  A Sommer; P H Liu
Journal:  Am J Med Genet       Date:  1984-03

10.  Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1).

Authors:  D H Cohn; B J Starman; B Blumberg; P H Byers
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

View more
  4 in total

1.  Unstable mutation in incontinentia pigmenti?

Authors:  E Hatchwell
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

2.  Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.

Authors:  S Kenwrick; H Woffendin; T Jakins; S G Shuttleworth; E Mayer; L Greenhalgh; J Whittaker; S Rugolotto; T Bardaro; T Esposito; M D'Urso; F Soli; A Turco; A Smahi; D Hamel-Teillac; S Lyonnet; J P Bonnefont; A Munnich; S Aradhya; C D Kashork; L G Shaffer; D L Nelson; M Levy; R A Lewis
Journal:  Am J Hum Genet       Date:  2001-10-22       Impact factor: 11.025

3.  Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).

Authors:  S Aradhya; G Courtois; A Rajkovic; R A Lewis; M Levy; A Israël; D L Nelson
Journal:  Am J Hum Genet       Date:  2001-02-08       Impact factor: 11.025

4.  Therapy resistant neonatal seizures, linear vesicular rash, and unusually early neuroradiological changes: incontinentia pigmenti: a case report, literature review and insight into pathogenesis.

Authors:  Gregor W Kaczala; Manuela A Messer; Ken J Poskitt; Juliette S Prendiville; Jane Gardiner; Christof Senger
Journal:  Eur J Pediatr       Date:  2007-10-16       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.